Results 181 to 190 of about 49,244 (195)

Ribavirin Therapy for Severe COVID-19: A Retrospective Cohort Study

International Journal of Antimicrobial Agents, 2020
Jinjun Jiang, Jiuling Chen, Sihua Wang
exaly  

Increased Mitochondrial Toxicity With Ribavirin in HIV/HCV Coinfection

Lancet, The, 2001
Gilles Hittinger, Alain Lafeuillade, Stéphane Chadapaud   +2 more
exaly  

Randomised Trial of Interferon α2b Plus Ribavirin for 48 Weeks or for 24 Weeks Versus Interferon α2b Plus Placebo for 48 Weeks for Treatment of Chronic Infection With Hepatitis C Virus

Lancet, The, 1998
Thierry Poynard, Vincent Bain, Janice K Albrecht   +2 more
exaly  

Ribavirin Uptake by Human Erythrocytes and the Involvement of Nitrobenzylthioinosine-Sensitive (Es)-Nucleoside Transporters

British Journal of Pharmacology, 1998
Paul Glue, Simon M Jarvis, Simon M Jarvis   +2 more
exaly  

Ribavirin Small-Particle Aerosol Treatment of Influenza.

Lancet, The, 1981
S Z Wilson, Vernon Knight, R B Couch
exaly  

Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C

Gastroenterology, 2010
Antonio Russo, Mariagrazia Rumi, Massimo Colombo   +2 more
exaly  

Metabolism and Antiviral Activity of Ribavirin

Virus Research, 2005
William B Parker
exaly  

Ribavirin

Reactions Weekly, 2013
openaire   +2 more sources

Effect of Ribavirin on Virus Load and Quasispecies Distribution in Patients Infected With Hepatitis C Virus

Journal of Hepatology, 1998
Christoph Sarrazin, Gerlinde Teuber, W K Roth   +2 more
exaly  

Simeprevir Plus Sofosbuvir, With or Without Ribavirin, to Treat Chronic Infection With Hepatitis C Virus Genotype 1 in Non-Responders to Pegylated Interferon and Ribavirin and Treatment-Naive Patients: The COSMOS Randomised Study

Lancet, The, 2014
Paul J Pockros, Mark Sulkowski
exaly